Skip to main content
. 2018 Sep 24;24:50. doi: 10.1186/s10020-018-0051-4

Fig. 2.

Fig. 2

Schematic showing different formats of immunotherapy binding to the antigen on the tumor cell: (1) monoclonal antibody, (2) bispecific antibody, (3) trispecific antibody, (4) bispecific T cell engager made from two single chain antibody fragments, and (5) CAR T cell therapy which is comprised of light chain and heavy chain variable fragments joined by a flexible linker